Gainesville, Fla. (June 16, 2016) – Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, announced today the full launch of the new Acapella® One Cervical Spacer System.
With the full launch of Acapella One, a cervical cage pre-assembled with integrated anchors, surgeons can restore disc height while providing integrated fixation to prevent device migration during anterior cervical spinal fusions. The Acapella One implants are available in two footprints, six heights and three sagittal profiles, including an anatomic domed design. The overall procedure is simplified by the unique design of the cage, which allows for single-step deployment of both the integrated anchors simultaneously into the vertebral endplates.
Exactech initially announced the pilot launch of the Acapella One device at the North American Spine Society 30th Annual Meeting in 2015. Since then, it has gained strong surgeon acceptance with more than 500 implanted to date. The continued development of the system includes simplified instrumentation designed to minimize surgical time and instrument processing while still ensuring superior performance.
“Exactech’s product development team is dedicated to providing a simplified surgical technique for surgeons and the potential for reduced operative time for patients,” said Bruce Thompson, Sr. Vice President and General Manager of Spine and Biologics at Exactech. “With the initial results from the pilot launch of the Acapella One system, we believe we will deliver on both of these goals.”
The full launch of Acapella One marks another milestone in the continued development of innovative products by Exactech Spine. The system rounds out Exactech’s cervical offerings, including the newly released Ascendant™ Titanium Coated Cervical cage, Ambassador™ Cervical plate and Gibralt® OCT Spinal System, which give surgeons a wide range of options for performing cervical fusion. Surgeons can learn more about the Exactech Spine at www.ExactechSpine.com.
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech can be found at https://aigrenoble.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at https://aigrenoble.com and https://www.hawkassociates.com.
This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
Executive Vice President of Finance & Chief Financial Officer
Julie Marshall or Frank Hawkins
Vice President, Corporate & Marketing Communication